NCT04055051
Hemophilia A, Hemophilia A and B, Liver Transplantation
The below information is taken directly from public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc. and has not been edited.
This study is designed as a multi-center, observational cohort study of participants with hemophilia A and B who have and have not undergone liver transplantation. Participants will be asked to complete health related quality of life questionnaires and provide medical history.
All
From 18 Years
No
Observational
86
2020-06-18
2023-05-10
Los Angeles, California, United States
San Francisco, California, United States
Peoria, Illinois, United States
Indianapolis, Indiana, United States
Scarborough, Maine, United States
Detroit, Michigan, United States
Rochester, Minnesota, United States
Rochester, New York, United States
Chapel Hill, North Carolina, United States
Columbus, Ohio, United States
Pittsburgh, Pennsylvania, United States
Houston, Texas, United States
Salt Lake City, Utah, United States
Green Bay, Wisconsin, United States
Milwaukee, Wisconsin, United States
Inclusion Criteria
Participants who meet the following inclusion criteria are eligible for enrollment into the study:
1. Congenital hemophilia A or B of any severity, who have and have not undergone a liver transplant;
2. Age > 18; and
3. Sex assigned at birth was male
Exclusion Criteria
Participants who fall into any of the following exclusion criteria at the time of screening are not eligible for enrollment into the study:
1. Age <18
*required fields
"*" indicates required fields